Bioceres Crop Solutions (BIOX) Research & Development (2016 - 2025)

Bioceres Crop Solutions has reported Research & Development for 10 years, with the latest figure at -$2.3 million in Q4 2025.

• Quarterly Research & Development fell 19.25% year-over-year to -$2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.5 million (down 18.78% YoY) and the FY2025 annual result came in at $14.9 million, down 13.2% from the prior year.
• Research & Development grew to -$2.3 million in Q4 2025 per BIOX's latest filing, from -$5.7 million in the prior quarter.
• Over five years, Research & Development peaked at $29.0 million in Q2 2024 and troughed at -$5.7 million in Q3 2025.
• A 5-year average of $2.8 million and a median of -$2.2 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2021 and 2022: Research & Development soared 1244.83% in 2021, then slumped 169.08% in 2022.
• Over 5 years, Research & Development stood at -$1.4 million in 2021, then plunged by 149.84% to -$3.5 million in 2022, then slipped by 5.36% to -$3.6 million in 2023, then surged by 45.96% to -$2.0 million in 2024, then declined by 19.25% to -$2.3 million in 2025.
• According to Business Quant data, Research & Development over the past three periods registered -$2.3 million, -$5.7 million, and $27.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.